Probiotic Supplementation as Prophylactic for Group B β-hemolytic Streptococcus (GBS) Infection
Launched by LIAQUAT UNIVERSITY OF MEDICAL & HEALTH SCIENCES · Jan 20, 2024
Trial Information
Current as of March 23, 2025
Completed
Keywords
ClinConnect Summary
There is strong scientific evidence that supports the correlation between bacterial vaginosis (BV), a term used to define a change in the vaginal ecosystem, and spontaneous preterm birth. Antibiotic treatments are recommended to counteract both the presence of S. agalactiae and the onset of BV. The latter, however, are not without risks, as they can in turn cause alterations in the vaginal microbiota and is associated with an increased risk of miscarriage.
Recent research have shown that probiotic treatment can help reduc the risk of preterm birth and positivity of Group B β-hemolytic stre...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant women in 24-36 weeks of gestation period
- • History of recurrent genitourinary and/or intestinal problems
- Exclusion Criteria:
- • Presence of neurological condition
- • History of cardiovascular disease
- • History of pulmonary disease
- • History of renal disease
- • Cancer
About Liaquat University Of Medical & Health Sciences
Liaquat University of Medical & Health Sciences (LUMHS) is a leading institution dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to improving patient outcomes, LUMHS integrates cutting-edge medical education, comprehensive healthcare services, and rigorous scientific inquiry. The university fosters a collaborative environment for researchers and healthcare professionals, aiming to translate scientific discoveries into practical applications. LUMHS is dedicated to upholding the highest ethical standards in clinical research, ensuring participant safety, and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Perugia, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0